Literature DB >> 7472551

Interim report on the radiosurgical treatment of cerebral arteriovenous malformations. The influence of size, dose, time, and technical factors on obliteration rate.

Y Yamamoto1, R J Coffey, D A Nichols, E G Shaw.   

Abstract

During the authors' initial 4-year experience with radiosurgery using the Leksell cobalt-60 gamma unit, they treated 121 patients with cerebral arteriovenous malformations (AVMs). The radiosurgical dose to the margin of the nidus was 20 Gy for lesions less than 2.0 cm in diameter (volume < or = 4.2 cm3); 18 Gy for malformations 2.1 to 3.0 cm in diameter (volume 4.2-14.1 cm3); and 16 Gy for malformations greater than 3.0 cm (volume > 14.1 cm3). Fifty-one patients underwent follow-up angiography between 1 and 3 years after treatment, and complete obliteration of the nidus was confirmed in 38 (74.5%) of these patients. Thirty-two (74.4%) of 43 AVMs with volumes of 10 cm3 or less and six (75%) of eight larger AVMs (volume 11-30 cm3) showed complete obliteration. Analysis of the time course of AVM nidus shrinkage and obliteration showed that most of the radiosurgically induced effect had occurred by 36 months after treatment. Retrospective analysis of the dose plans for 10 AVMs that were not obliterated by 36 months after gamma knife radiosurgery at the authors' institution (eight cases) or elsewhere (two cases) revealed that six AVMs had not been covered completely by the prescribed isodose. Six (5%) of the 121 patients developed neurological deficits as a direct result of radiosurgical treatment. The authors infer from these data that malformations up to 30 cm3 in volume (approximately 4.0 cm in average diameter) can be treated effectively with an acceptably low complication rate using a radiosurgical dose of 16 Gy to the margin of the nidus. The obliteration rate for the larger malformations that were treated with a dose of 16 to 18 Gy appears to be similar to that for smaller ones treated with 18 to 20 Gy. As more experience accrues using radiosurgery to treat AVMs, patient selection criteria and the variables associated with successful obliteration of the nidus should become more clearly defined.

Entities:  

Mesh:

Year:  1995        PMID: 7472551     DOI: 10.3171/jns.1995.83.5.0832

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  17 in total

Review 1.  Surgical management of pediatric cerebral arteriovenous malformations.

Authors:  David Rubin; Alejandro Santillan; Jeffrey P Greenfield; Mark Souweidane; Howard A Riina
Journal:  Childs Nerv Syst       Date:  2010-07-02       Impact factor: 1.475

2.  Stereotactic radiosurgery for brain arteriovenous malformations: quantitative MR assessment of nidal response at 1 year and angiographic factors predicting early obliteration.

Authors:  S Nagaraja; K J Lee; S C Coley; D Capener; L Walton; A A Kemeny; I D Wilkinson; P D Griffiths
Journal:  Neuroradiology       Date:  2006-08-31       Impact factor: 2.804

3.  A challenging entity of endovascular embolization with ONYX for brainstem arteriovenous malformation: Experience from 13 cases.

Authors:  Hengwei Jin; Zhan Liu; Qing Chang; Chang Chen; Huijian Ge; Xianli Lv; Youxiang Li
Journal:  Interv Neuroradiol       Date:  2017-06-14       Impact factor: 1.610

4.  Predictors for occlusion of cerebral AVMs following radiation therapy : Radiation dose and prior embolization, but not Spetzler-Martin grade.

Authors:  Stefan Knippen; Florian Putz; Sabine Semrau; Ulrike Lambrecht; Arzu Knippen; Michael Buchfelder; Sven Schlaffer; Tobias Struffert; Rainer Fietkau
Journal:  Strahlenther Onkol       Date:  2016-10-18       Impact factor: 3.621

5.  Brain arteriovenous malformations: measurement of nidal volume using a combination of static and dynamic magnetic resonance angiography techniques.

Authors:  S Nagaraja; D Capener; S C Coley; K J Lee; I D Wilkinson; A A Kemeny; P D Griffiths
Journal:  Neuroradiology       Date:  2005-04-15       Impact factor: 2.804

6.  Embolization of Arteriovenous Malformation. Efficacy and Safety of Preoperative Embolization Followed by Surgical Resection of AVM.

Authors:  H Nagashima; K Hongo; S Kobayashi; T Takamae; H Okudera; J I Koyama; F Oya; Y Matsumoto
Journal:  Interv Neuroradiol       Date:  2008-05-15       Impact factor: 1.610

7.  Symptomatic Radionecrosis after AVM Stereotactic Radiosurgery. Study of 16 Consecutive Patients.

Authors:  S Finitsis; R Anxionnat; S Bracard; A Lebedinsky; C Marchal; L Picard
Journal:  Interv Neuroradiol       Date:  2005-06-17       Impact factor: 1.610

8.  Radiosurgical management of pediatric arteriovenous malformations.

Authors:  Douglas Kondziolka; Hideyuki Kano; Huai-che Yang; John C Flickinger; L Lunsford
Journal:  Childs Nerv Syst       Date:  2010-07-06       Impact factor: 1.475

9.  Radiosurgical considerations in the treatment of large cerebral arteriovenous malformations.

Authors:  Sung Ho Lee; Young Jin Lim; Seok Keun Choi; Tae Sung Kim; Bong Arm Rhee
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

10.  Control of epilepsy associated with cerebral arteriovenous malformations after radiosurgery.

Authors:  H Kurita; S Kawamoto; I Suzuki; T Sasaki; M Tago; A Terahara; T Kirino
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.